David Stout, GlaxoSmithKline's former president of pharmaceutical operations, left the company in December 2007 after he was passed over for the position of CEO. He turned down a $4 million incentive package and a spot on the company's board.
Related Articles:
Musical chairs at GSK leaves Stout out
GSK runners-up get $4M, board seat
GSK CEO also-rans may get on board
At GSK, a public race for the top spot
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site MapTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2009 FierceMarkets, Inc. All rights reserved. |
 |